Answer
Breastfeeding should be discontinued during Retsevmo (selpercatinib) treatment and for at least one week after the last dose.
Sources for this answer
- Retsevmo 40mg and 80mg film-coated tabletsEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked